DOCSLIB.ORG

Cross-Priming of the Melanoma Antigen, Melan-A, by Skin Dendritic Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cross-Priming of the Melanoma Antigen, Melan-A, by Skin Dendritic Cells Cross-priming of the melanoma antigen, Melan-A, by skin dendritic cells Katie Harriette Best Supervisor: Dr Muzlifah Haniffa Human Dendritic Cell Laboratory Institute of Cellular Medicine Masters by Research 2013-2014 Word Count: 951 excluding title page, acknowledgements and references. Cross-priming of the melanoma antigen, Melan-A, by skin dendritic cells Introduction Cutaneous melanoma is the most dangerous and aggressive form of skin cancer, characterised by the transformation and invasive growth of melanocytes1. The incidence rate of melanoma is rising worldwide2-3. Radical excision of the primary tumour is currently the only curative treatment option4, however surgery is rarely an option for patients with metastatic disease. The prognostic outlook for metastatic disease is bleak, with two-year overall survival rates of 10%5. Melanoma has poor sensitivity to traditional treatment methods involving chemotherapy and radiation therapy. Furthermore, recently approved immunotherapies vemurafenib and ipilimumab have proven to be of limited, objective clinical use due to resistance and poor response respectively1,6-7. The latter is partly due to paucity in knowledge about the biological function of the antigen presenting cells (APCs) responsible for processing melanoma- associated antigens and generating a cytotoxic anti-melanoma immune response. Dendritic cells (DCs) constitute a heterogenous population8 of professional APCs, with a pivotal role in linking the innate and adaptive immune system. DCs are found in peripheral tissues such as the skin, where they sample the local microenvironment and migrate to the draining lymph nodes in order to interact with T cells and initiate immune responses. DCs harbour the unique capacity to induce de novo antigen-specific cytotoxic T lymphocyte (CTL) responses by the phenomenon of cross-priming, see Figure 1. The human immune system is capable of mounting a cytotoxic response against melanoma9, and thus enhancing specific tumour-killing immune responses against melanoma presents as an attractive therapeutic strategy. To date, several melanoma-associated antigens have been identified and the strikingly immunodominant10, well characterised melanoma-associated antigen, Melan-A, has generated considerable clinical interest with regards to developing an anti-melanoma vaccine11. As critical regulators of immune responses, DCs are of significant importance in designing rational anti-cancer vaccines12-13. Very little is known about how human skin DCs process cancer antigens to generate tumour killing responses and whether this can be clinically translated to advance cancer therapy. Demonstrating the ability of skin DCs to elicit a cytotoxic anti-melanoma response will facilitate the development of novel anti-melanoma immunotherapies through direct targeting of cross-priming DC subsets. The aim of this study was to test the ability of human skin APCs to cross-prime naïve CD8+ T cells against the melanoma-associated antigen, Melan-A, in vitro. Figure 1. Diagram of cross-priming. Migratory skin DCs uptake Melan-A antigen in the periphery and traffic to the draining lymph node. With the help of CD4+ T cells, DCs are licensed to present Melan-A antigenic peptide via their major histocompatibility complex (MHC) class I molecule to naïve CD8+ T cells. The naïve CD8+ T cells are cross-primed against Melan-A and enter the circulation as Melan-A-specific effector cytotoxic T lymphocytes (CTLs). Methods To test the ability of human skin APCs to cross-prime naïve CD8+ T cells against the melanoma-associated antigen, Melan-A, I co-cultured naïve CD8+ T cells from HLA-A*02+ peripheral blood stem cells with allogeneic HLA-A*02+ skin APCs loaded with 25µg/ml Melan-A protein overnight, for 9 days. For a positive control, skin APCs were loaded with Melan-A short peptide. For a negative control, skin APCs were not loaded with Melan-A protein or peptide. Skin APCs and naïve CD8+ T cells were isolated from plastic surgery patients’ surplus, healthy skin samples and peripheral blood stem cells respectively, by fluorescence activated cell sorting (FACS), see Figure 2. After 9 days, the induction of Melan-A-specific cytotoxic T lymphocytes was determined by flow cytometry analysis of tetramer binding, see Figure 3. Figure 2. Diagram of fluorescence activated cell sorting (FACS). Figure 3. Diagram showing A) cross-priming of a naive CD8+ T cells against Melan-A by an antigen presenting cell (APC), B) the structure of an MHC class I/Melan-A peptide tetramer, and C) tetramer binding to a Melan-A-specific cytotoxic T lymphocyte (CTL). Results and Discussion I investigated the ability of five different skin APCs (dermal CD14+ cells, CD1c+ DCs, CD141hi DCs, macrophages and epidermal Langerhans cells) to cross-prime naive CD8+ T cells against Melan-A in vitro. The results from this study show that epidermal Langerhans cells (LCs) are capable of cross- priming naïve CD8+ T cells against the melanoma-associated antigen, Melan-A, in vitro see Figure 4. Although it is difficult to prove unequivocally LCs are a cross-priming DC subset, these findings complement evidence showing LCs to be cross-presenting DCs14-16. There is ample evidence to support the hypothesis that LCs are efficient at cross-priming naïve CD8+ T cells16-19. The cross-priming ability of dermal CD14+ cells, CD1c+ DCs, CD141hi DCs and macrophages in vitro was unconvincing due to the relatively high detection of tetramer+ cells in the negative control, see Figure 4. However, without further investigation, the potential cross-priming ability of these dermal APCs cannot be disregarded. Figure 4. Percentage of CD3+CD8+ T cells induced to tetramer+/Melan-A-specific cytotoxic T lymphocytes after a 9 day co-culture of naive CD8+ T cells with unloaded, Melan-A short peptide loaded or Melan-A protein loaded skin APCs. Composite data for two experiments is shown with the mean. Conclusions Dendritic cell (DC) mediated cross-priming of endogenous cancer-associated antigens is essential for the induction of de novo cancer antigen-specific cytotoxic T lymphocyte responses. DC subsets with functional specialisations have been identified in human skin, including migratory cross-presenting DCs20 but cross-priming DCs have not been isolated, despite their potential importance in immunity and generating an anti-tumour cytotoxic response. This study shows epidermal LCs are capable of effectively cross-priming naïve CD8+ T cells against Melan-A in vitro. However, the number of donors is not adequate to reach statistical significance and merit LCs with the definitive status of a cross-priming DC subset; further investigation is required in order to consolidate these results. Ultimately, these findings will facilitate the development of novel anti-melanoma immunotherapies, through direct targeting of cross-priming DC subsets. Acknowledgements Human Dendritic Cell Lab I would like to thank the plastic surgery patients for participating in this study, Tara Shrestha for coordinating the skin samples, Emma Matthews at the Stem Cell Transplantation Research Group for the provision of peripheral blood stem cells, Andrew Fuller and David Macdonald at the Flow Cytometry core facility for their assistance with FACS, Elizabeth Poyner for her advice, Merry Gunawan for her help and assistance, Muzlifah Haniffa for her guidance and supervision, and Professor Matthew Collin and everyone else at the Human Dendritic Cell Lab for their support and encouragement. This work was supported by grants from the British Association of Dermatologists, the British Skin Foundation and the Wellcome Trust. References 1. Garbe, C., et al., Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012. European Journal of Cancer, 2012. 48(15): p. 2375-2390. 2. Maio, M., Melanoma as a model tumour for immuno-oncology. Annals of Oncology, 2012. 23(8): p. 10-14. 3. de Vries, E. and J.W. Coebergh, Melanoma incidence has risen in Europe. BMJ, 2005. 331(7518): p. 698. 4. Oosterhoff, D., et al., The Dermis as a Portal for Dendritic Cell-Targeted Immunotherapy of Cutaneous Melanoma. Current Topics in Microbiology and Immunology, 2012. 351: p. 181-220. 5. Korn, E.L., et al., Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progresion-free and overall survival benchmarks for future phase II trials. Journal of Clinical Oncology, 2008. 26: p. 527-534. 6. Chapman, P.B., et al., Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New England Journal of Medicine, 2011. 364(26): p. 2507-2516. 7. Eggermont, A.M.M. and C. Robert, Melanoma in 2011: a new paradigm for tumor drug development. Nature Reviews Clinical Oncology, 2012. 9: p. 74-76. 8. Lindstedt, M., K. Lundberg, and C.A. Borrebaeck, Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. Journal of Immunology, 2005. 175(8): p. 4839-4846. 9. Hai-Liang, G.E., et al., Identification of Melanoma-specific Peptide Epitopes by HLA- A2.1-restricted Cytotoxic T Lymphocytes. Acta Biochimica et Biophysica Sinica, 2006. 38(2): p. 110-118. 10. Bettinotti, M.P., et al., Stringent allele/epitope requirements for MART-1/Melan-A immunodominance: implications for peptide-based immunotherapy. Journal of Immunology, 1998. 161(2): p. 877-889. 11. Robson, N.C., et al., Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery. Blood, 2010. 116(2): p. 218-225. 12. Banchereau, J., et al., Harnessing human dendritic cell subsets to design novel vaccines. Annals of the New York Academy of Sciences, 2009. 1174: p. 24-32. 13. Steinman, R.M., Dendritic cells and vaccines. Proceedings Baylor University Medical Center 2008. 21: p. 3-8. 14. Lui, G., et al., Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells. PLoS ONE, 2009. 4(9): p. e7111. 15. Nizzoli, G., et al., Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.
Load more

Recommended publications
  • Abstracts Genome 10K & Genome Science 29 Aug - 1 Sept 2017 Norwich Research Park, Norwich, Uk
    Genome 10K c ABSTRACTS GENOME 10K & GENOME SCIENCE 29 AUG - 1 SEPT 2017 NORWICH RESEARCH PARK, NORWICH, UK Genome 10K c 48 KEYNOTE SPEAKERS ............................................................................................................................... 1 Dr Adam Phillippy: Towards the gapless assembly of complete vertebrate genomes .................... 1 Prof Kathy Belov: Saving the Tasmanian devil from extinction ......................................................... 1 Prof Peter Holland: Homeobox genes and animal evolution: from duplication to divergence ........ 2 Dr Hilary Burton: Genomics in healthcare: the challenges of complexity .......................................... 2 INVITED SPEAKERS ................................................................................................................................. 3 Vertebrate Genomics ........................................................................................................................... 3 Alex Cagan: Comparative genomics of animal domestication .......................................................... 3 Plant Genomics .................................................................................................................................... 4 Ksenia Krasileva: Evolution of plant Immune receptors ..................................................................... 4 Andrea Harper: Using Associative Transcriptomics to predict tolerance to ash dieback disease in European ash trees ............................................................................................................
    [Show full text]
  • Research Focuses on the Gen- Maureen R
    This Month Surveying resident physician exposure to COVID-19 2 Alternative mechanisms underlying acute graft- versus-host disease 4 Targeting melanocortin signaling alleviates cachexia 5 Intrathecal gene therapy improves neuromuscular deterioration in canine model 6 September 2020 JCI This Month is a summary of the most recent articles in The Journal of Clinical Investigation and JCI Insight jci.org/this-month Placental infection by SARS–CoV-2 p. 2 Scan for the digital version of JCI This Month. Journal of Clinical Investigation Consulting Editors Soman N. Abraham Richard T. D'Aquila Katherine A. High Terri Laufer David J. Pinsky M. Celeste Simon John S. Adams Alan Daugherty Helen H. Hobbs Mitchell A. Lazar Edward Plow Mihaela Skobe Qais Al-Awqati Sudhansu Dey Ronald Hoffman Brendan Lee Catherine Postic Donald Small Kari Alitalo Anna Mae Diehl V. Michael Holers William M.F. Lee Alice S. Prince Lois Smith Dario C. Altieri Harry C. Dietz III Steven Holland Rudolph L. Leibel Louis J. Ptáček Akrit Sodhi Masayuki Amagai Gianpietro Dotti David Holtzman Wayne I. Lencer Luigi Puglielli Weihong Song Brian H. Annex Michael Dustin Michael J. Holtzman Jon D. Levine Pere Puigserver Ashley L. St. John M. Amin Arnaout Connie J. Eaves Lawrence B. Holzman Ross L. Levine Bali Pulendran Jonathan Stamler Alan Attie Dominique Eladari Tamas L. Horvath Klaus Ley Ellen Puré Colin L. Stewart Jane E. Aubin Joel K. Elmquist Gokhan S. Hotamisligil Rodger A. Liddle Susan E. Quaggin Doris Stoffers Michael F. Beers Stephen G. Emerson Steven R. Houser Richard Locksley Marlene Rabinovitch Warren Strober Vann Bennett Jonathan A.
    [Show full text]
  • Correlation-Based Feature Selection for Clustering Single-Cell RNA Sequencing Data
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.07.330563; this version posted March 5, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. DUBStepR: correlation-based feature selection for clustering single-cell RNA sequencing data Bobby Ranjan , Wenjie Sun , Jinyu Park , Kunal Mishra , Ronald Xie , Fatemeh Alipour , Vipul Singhal , Florian Schmidt , Ignasius Joanito , Nirmala Arul Rayan , Michelle Gek Liang Lim , and Shyam Prabhakar 1Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, A*STAR, 60 Biopolis Street, Singapore - 138672 Feature selection (marker gene selection) is widely believed to ent approaches have been developed in this space. Moreover, improve clustering accuracy, and is thus a key component of there have been only a handful of systematic benchmarking single cell clustering pipelines. However, we found that the per- studies of scRNA-seq feature selection methods (7–9). A formance of existing feature selection methods was inconsistent good feature selection algorithm is one that selects cell-type- across benchmark datasets, and occasionally even worse than specific (DE) genes as features, and rejects the remaining without feature selection. Moreover, existing methods ignored genes. More importantly, the algorithm should select features information contained in gene-gene correlations. We therefore that optimize the separation between biologically distinct cell developed DUBStepR (Determining the Underlying Basis using Stepwise Regression), a feature selection algorithm that lever- clusters. A comprehensive benchmarking study of feature se- ages gene-gene correlations with a novel measure of inhomo- lection methods would ideally use both of these metrics.
    [Show full text]
  • Immune Suppressive Landscape in the Human Esophageal Squamous Cell
    ARTICLE https://doi.org/10.1038/s41467-020-20019-0 OPEN Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment ✉ Yingxia Zheng 1,2,10 , Zheyi Chen1,10, Yichao Han 3,10, Li Han1,10, Xin Zou4, Bingqian Zhou1, Rui Hu5, Jie Hao4, Shihao Bai4, Haibo Xiao5, Wei Vivian Li6, Alex Bueker7, Yanhui Ma1, Guohua Xie1, Junyao Yang1, ✉ ✉ ✉ Shiyu Chen1, Hecheng Li 3 , Jian Cao 7,8 & Lisong Shen 1,9 1234567890():,; Cancer immunotherapy has revolutionized cancer treatment, and it relies heavily on the comprehensive understanding of the immune landscape of the tumor microenvironment (TME). Here, we obtain a detailed immune cell atlas of esophageal squamous cell carcinoma (ESCC) at single-cell resolution. Exhausted T and NK cells, regulatory T cells (Tregs), alternatively activated macrophages and tolerogenic dendritic cells are dominant in the TME. Transcriptional profiling coupled with T cell receptor (TCR) sequencing reveal lineage con- nections in T cell populations. CD8 T cells show continuous progression from pre-exhausted to exhausted T cells. While exhausted CD4, CD8 T and NK cells are major proliferative cell components in the TME, the crosstalk between macrophages and Tregs contributes to potential immunosuppression in the TME. Our results indicate several immunosuppressive mechanisms that may be simultaneously responsible for the failure of immuno-surveillance. Specific targeting of these immunosuppressive pathways may reactivate anti-tumor immune responses in ESCC. 1 Department of Laboratory Medicine, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2 Institute of Biliary Tract Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 3 Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
    [Show full text]
  • Fertilization & Implantation Systems
    Spring 2020 – Systems Biology of Reproduction Discussion Outline – Fertilization & Implantation Systems Michael K. Skinner – Biol 475/575 CUE 418, 10:35-11:50 am, Tuesday & Thursday April 16, 2020 Week 14 Fertilization & Implantation Systems Primary Papers: 1. Teperek, et al. (2016) Genome Research 26:1034. 2. Brosens, et al. (2014) Scientific Reports 4:3894. 3. Vento-Tormo, et al. (2018) Nature 563(7731):347-353. Discussion Student 9: Reference 1 above • What was the experimental design and objectives? • What impact on the developing embryo was observed? • Can sperm epigenetic alterations modify the embryo? Student 10: Reference 2 above • How do abnormal embryos influence the endometrial cells? • What transcriptional influences were observed? • How do component embryos promote a supportive uterine environment? Student 11: Reference 3 above • What was the experimental design and technology? • What maternal-fetal interface interactions were identified? • What new insights for maternal-fetal interface were found to be critical for placentation and reproductive success? Downloaded from genome.cshlp.org on March 30, 2018 - Published by Cold Spring Harbor Laboratory Press Research Sperm is epigenetically programmed to regulate gene transcription in embryos Marta Teperek,1,2,6 Angela Simeone,1,2,6 Vincent Gaggioli,1,2 Kei Miyamoto,1,2 George E. Allen,1 Serap Erkek,3,4,7 Taejoon Kwon,5 Edward M. Marcotte,5 Philip Zegerman,1,2 Charles R. Bradshaw,1 Antoine H.F.M. Peters,3,4 John B. Gurdon,1,2 and Jerome Jullien1,2 1Wellcome Trust/Cancer Research
    [Show full text]
  • Cellular and Molecular Regulation of Immunity in Barrier Organs Friday 27Th November 2015, Munich
    SFB 1054 International Symposium CELLULAR AND MOLECULAR REGULATION OF IMMUNITY IN BARRIER ORGANS Friday 27th November 2015, Munich With generous support by: SFB 1054 Control and Plasticity of Cell-Fate Decisions in the Immune System CELLULAR AND MOLECULAR SFB 1054 REGULATION OF IMMUNITY IN BARRIER ORGANS Dear SFB members, dear guests, Imprint I would like to welcome you to the symposium „Cellular and molecular regulation of immunity in barrier organs“ organized by our Collaborative Research Center (SFB 1054). Immune cells SFB 1054 Office in epithelial barrier organs, such as skin, lung and intestine are constantly exposed to microbial Institute for Immunology and environmental factors, which shape their development and function in a tissue-specific Ludwig-Maximilians-Universität München manner. Dendritic cells, macrophages, innate lymphoid cells and T cells are critically involved in Goethestr. 31 tissue homeostasis and immune defense in these organs. High-throughput siRNA and CRISPR/ 80336 München Cas9 technologies have opened the door to discovery of molecules with previously unknown function which play central roles in the development and activity of these immune cell types in Phone: +49 (0)89 2180-75680 / -75669 their specific tissue environment. E-Mail: [email protected] For this symposium, which is financed by the German Research Foundation gender equality funds, we invited six accomplished female immunologists, who are leading researchers in this field. Our aim is to encourage our female PhD students and postdocs to further pursue a scientific career and to increase the number of women in leading positions in Immunology. Universities and other research institutions face the challenge to attract and retain more women in science.
    [Show full text]
  • Human Cell Atlas Study Reveals Maternal Immune System Modifications in Early Pregnancy 14 November 2018
    Human Cell Atlas study reveals maternal immune system modifications in early pregnancy 14 November 2018 many of these problems occur in the first few weeks of the pregnancy, when the placenta is formed. The fetus creates a placenta that surrounds it in the uterus to provide nutrients and oxygen. This is in contact with the mother where it implants into the lining of the uterus—known as the decidua—to create a good blood supply for the placenta. Research on the interface between mother and fetus could help answer many vital questions, including how the mother's immune system is modified to allow both mother and the developing fetus to coexist. However, until now this area has not been well studied. Credit: CC0 Public Domain To understand this area, researchers studied more than 70,000 single cells from first trimester pregnancies. Using single-cell RNA and DNA The first Human Cell Atlas study of early sequencing they identified maternal and fetal cells pregnancy in humans has shown how the function in the decidua and placenta, and found how these of the maternal immune system is affected by cells cells were interacting with one another. They from the developing placenta. Researchers from discovered that the fetal and maternal cells were the Wellcome Sanger Institute, Newcastle using signals to talk to each other, and this University and University of Cambridge used conversation enabled the maternal immune system genomics and bioinformatics approaches to map to support fetal growth. over 70,000 single cells at the junction of the uterus and placenta. This revealed how the cells Dr.
    [Show full text]
  • Comparative Genomics Analysis of Mononuclear Phagocyte Subsets
    Journal of Immunological Methods 432 (2016) 35–49 Contents lists available at ScienceDirect Journal of Immunological Methods journal homepage: www.elsevier.com/locate/jim Research paper Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1+ DCs in mouse and human and distinguishes them from Langerhans cells Sabrina Carpentier a,1,Thien-PhongVuManhb,1,RabieChelbib, Sandrine Henri b, Bernard Malissen b, Muzlifah Haniffa c,⁎, Florent Ginhoux d,⁎⁎,MarcDalodb,⁎⁎⁎ a Mi-mAbs (C/O Centre d'Immunologie de Marseille-Luminy), F-13009 Marseille, France b Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Inserm, U1104, CNRS UMR7280, F-13288 Marseille Cedex 09, France c Human Dendritic Cell Laboratory, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK d Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore article info abstract Article history: Dendritic cells (DC) are mononuclear phagocytes which exhibit a branching (dendritic) morphology and excel at Received 28 October 2015 naïve T cell activation. DC encompass several subsets initially identified by their expression of cell surface mole- Received in revised form 1 February 2016 cules and later shown to possess distinct functions. DC subset differentiation is orchestrated by transcription fac- Accepted 25 February 2016 tors, growth factors and cytokines. Identifying DC subsets is challenging as very few cell surface molecules are Available online 7 March 2016 uniquely expressed on any one of these cell populations. There is no standard consensus to identify mononuclear phagocyte subsets; varying antigens are employed depending on the tissue and animal species studied and be- Keywords: fi Dendritic cells tween laboratories.
    [Show full text]
  • Let Them Eat Cake Celebrating the Day of Immunology Throughout Australasia
    2016 ASI JUNE NEWSLETTER Let them eat cake Celebrating the Day of Immunology throughout Australasia Also in this issue Contact Us Australasian Society for Immunology Inc. • Knowledge Nation - Misty • Jaw-dropping beauty from PO Box 7108, Upper Ferntree Gully VIC 3156 Jenkins and DNA Nation Snapshots of the Immune Australia • Getting the news across - Peter system exhibition in Melbourne P: +61 3 9756 0128 Doherty interviewed by Erika • More delcious pictures of cake! E: [email protected] Duan International Congress of Immunology 2016 IMMUNOTHERAPY: HARNESSING THE POWER OF THE IMMUNE SYSTEM www.ici2016.org ICI 2016 Hosted by Invitation from the ICI 2016 President ICI 2016 promises to be an unforgettable event that will bring together delegates from all over the world. We anticipate over 3000 participants, including international leaders at the forefront of the discipline that will present the most recent advances in basic immunology and clinical treatments. This is an opportunity to be part of a major international immunology meeting in Australia as the last ICI was held in Sydney back in 1977. The Congress will provide a key networking and educational interface for colleagues from industry, university, health providers and independent research organisations to come together. Jose Villadangos President, International Congress of Immunology 2016 Peter Doherty Institute and Bio21 Institute, The University of Melbourne AXM0440 ICI 2016 Double Page Spread update.indd 2 13/05/2016 11:13 AM SOME OF THE CONFIRMED SPEAKERS Shizuo
    [Show full text]
  • Mobilizing Monocytes to Cross-Present Circulating Viral Antigen in Chronic Infection Adam J
    Research article Mobilizing monocytes to cross-present circulating viral antigen in chronic infection Adam J. Gehring,1 Muzlifah Haniffa,2,3 Patrick T. Kennedy,4 Zi Zong Ho,1 Carolina Boni,5 Amanda Shin,3 Nasirah Banu,1 Adeline Chia,1 Seng Gee Lim,6 Carlo Ferrari,5 Florent Ginhoux,3 and Antonio Bertoletti1,7,8 1Infection and Immunity Programme, Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*Star), Singapore. 2Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom. 3Singapore Immunology Network, Agency for Science Technology and Research (A*Star), Singapore. 4Center for Digestive Disease, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, United Kingdom. 5Unit of Infectious Diseases and Hepatology, Laboratory of Viral Immunopathology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy. 6Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 7Program Emerging Viral Diseases, Duke-NUS Graduate Medical School, Singapore. 8Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Selection of antigens for therapeutic vaccination against chronic viral infections is complicated by pathogen genetic variations. We tested whether antigens present during persistent viral infections could provide a per- sonalized antigenic reservoir for therapeutic T cell expansion in humans. We focused our study on the HBV surface antigen (HBsAg), which is present in microgram quantities in the serum of chronic HBV patients. We demonstrated by quantitative fluorescent microscopy that, out of 6 professional APC populations in the cir- culation, only CD14 monocytes (MNs) retained an HBsAg depot. Using TCR-redirected CD8+ T cells specific for MHC-I–restricted HBV epitopes, we showed that, despite being constantly exposed to antigen, ex vivo– isolated APCs did not constitutively activate HBV-specific CD8+ T cells.
    [Show full text]
  • Rapid Detection of Dendritic Cell and Monocyte Disorders Using CD4 As a Lineage Marker of the Human Peripheral Blood Antigen-Presenting Cell Compartment
    ORIGINAL RESEARCH ARTICLE published: 27 December 2013 doi: 10.3389/fimmu.2013.00495 Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment Laura Jardine 1, Dawn Barge 2, Ashley Ames-Draycott 1, Sarah Pagan1, Sharon Cookson1, Gavin Spickett 2, Muzlifah Haniffa1, Matthew Collin1* and Venetia Bigley 1 1 Human Dendritic Cell Laboratory, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK 2 Clinical Immunology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK Edited by: Dendritic cells (DCs) and monocytes are critical regulators and effectors of innate and Lisa Helene Butterfield, University of adaptive immune responses. Monocyte expansion has been described in many pathologi- Pittsburgh, USA cal states while monocyte and DC deficiency syndromes are relatively recent additions to Reviewed by: Geanncarlo Lugo-Villarino, Centre the catalog of human primary immunodeficiency disorders. Clinically applicable screening national de la recherche scientifique, tests to diagnose and monitor these conditions are lacking. Conventional strategies for France identifying human DCs and monocytes have been based on the use of a lineage gate to Allan B. Dietz, Mayo Clinic, USA exclude lymphocytes, thus preventing simultaneous detection of DCs, monocytes, and Sylvia Kiertscher, University of California Los Angeles, USA lymphocyte subsets. Here we demonstrate that CD4 is a reliable lineage marker for the human peripheral
    [Show full text]
  • Human Skin Dendritic Cells in Health and Disease
    Haniffa M, Gunawan M, Jardine L. Human skin dendritic cells in health and disease. Journal of Dermatological Science 2015, 77(2), 85-92. Copyright: © 2014 The Authors. Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license http://creativecommons.org/licenses/bync- nd/3.0/ DOI link to article: http://dx.doi.org/10.1016/j.jdermsci.2014.08.012 Date deposited: 06/07/2015 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License Newcastle University ePrints - eprint.ncl.ac.uk Journal of Dermatological Science 77 (2015) 85–92 Contents lists available at ScienceDirect Journal of Dermatological Science jo urnal homepage: www.jdsjournal.com Invited Review Article Human skin dendritic cells in health and disease a,b, a a Muzlifah Haniffa *, Merry Gunawan , Laura Jardine a Institute of Cellular Medicine, Newcastle University, NE2 4HH, UK b Department of Dermatology, Newcastle Upon Tyne NHS Trust, NE1 4LP, UK A R T I C L E I N F O S U M M A R Y Article history: Dendritic cells (DCs) are specialized antigen presenting cells abundant in peripheral tissues such as skin Received 18 June 2014 where they function as immune sentinels. Skin DCs migrate to draining lymph node where they interact Received in revised form 19 August 2014 with naı¨ve T cells to induce immune responses to microorganisms, vaccines, tumours and self-antigens. In Accepted 28 August 2014 this review, we present the key historical developments and recent advances in human skin DC research.
    [Show full text]